12'-hydroxy-2'-(1-methylethyl)-5'-(1-methylpropyl)-3',6',18-trioxo-9,10-dihydroergotaman (7236-51-3)

Identification
Name:	12'-hydroxy-2'-(1-methylethyl)-5'-(1-methylpropyl)-3',6',18-trioxo-9,10-dihydroergotaman
CAS:	7236-51-3
Molecular Formula:	C₃₂H₄₃N₅O₅
Molecular Weight:	577.7143
InChI:	InChI=1/C32H43N5O5/c1-6-18(4)27-29(39)36-12-8-11-25(36)32(41)37(27)30(40)31(42-32,17(2)3)34-28(38)20-13-22-21-9-7-10-23-26(21)19(15-33-23)14-24(22)35(5)16-20/h7,9-10,15,17-18,20,22,24-25,27,33,41H,6,8,11-14,16H2,1-5H3,(H,34,38)
Molecular Structure:
Properties
Flash Point:	466.9°C
Boiling Point:	848.4°C at 760 mmHg
Density:	1.36g/cm³
Refractive index:	1.667
Flash Point:	466.9°C
Safety Data

Other Product

(5'alpha,10alpha)-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-3',6',18-trioxo-9,10-dihydroergotaman 2,3-dihydroxybutanedioate (salt)
(5'alpha,10alpha)-12'-hydroxy-2'-methyl-5'-(2-methylpropyl)-3',6',18-trioxo-9,10-dihydroergotaman
5-hydroxy-L-tryptophan - (5'alpha,10alpha)-5'-benzyl-12'-hydroxy-2'-(1-methylethyl)-3',6',18-trioxo-9,10-dihydroergotaman (1:1)
(5'alpha,10alpha)-5'-tert-butyl-12'-hydroxy-2'-methyl-3',6',18-trioxo-9,10-dihydroergotaman methanesulfonate (1:1)
(5'alpha,10alpha)-5'-benzyl-12'-hydroxy-3',6',18-trioxo-2'-propyl-9,10-dihydroergotaman methanesulfonate (1:1)
Ergotaman-3',6',18-trione,12'-hydroxy-2'-(1-methylethyl)-5'-[(1S)-1-methylpropyl]-, (5'a)-
Ergotaman-3',6',18-trione,12'-hydroxy-2'-(1-methylethyl)-5'-[(1S)-1-methylpropyl]-, (5'a,10a)-
Ergotaman-3',6',18-trione,2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-, (5'a)-
Ergotaman-3',6',18-trione,12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-, (5'a,8a)-
Ergotaman-3',6',18-trione,12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-, (5'a)-
2,5,11,14-Tetraazapentadecanoic acid,3-(2-amino-2-oxoethyl)-6-(cyclohexylmethyl)-7-hydroxy-9-(1-methylethyl)-12-(1-methylpropyl)-4,10,13-trioxo-15-(2-pyridinyl)-, phenylmethyl ester
2,5,11,14-Tetraazapentadecanoic acid,3-(2-amino-2-oxoethyl)-6-(cyclohexylmethyl)-7-hydroxy-9-(1-methylethyl)-12-(1-methylpropyl)-4,10,13-trioxo-15-(2-pyridinyl)-, 1,1-dimethylethylester
Ergotaman-3',6',18-trione,9,10-dihydro-12'-hydroxy-2'-(1-methylethyl)-5'-(1-methylpropyl)-, [5'a(R),10a]- (9CI)
2,5,11,14-Tetraazapentadecanoic acid,6-(cyclohexylmethyl)-7-hydroxy-3-(1H-imidazol-4-ylmethyl)-2-methyl-9-(1-methylethyl)-12-(1-methylpropyl)-4,10,13-trioxo-15-(2-pyridinyl)-,1,1-dimethylethyl ester
Ergotaman-3',6',18-trione,2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-, (5'a,8a)- (9CI)
Ergotaman-3',6',18-trione,9,10-dihydro-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-, (5'a,10a)-
(5'alpha)-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-3',6',18-trioxoergotaman 2,3-dihydroxybutanedioate (salt)
12'-Hydroxy-2'-methyl-5'α-[(S)-1-methylpropyl]ergotaman-3',6',18-trione
Ergotaman-3',6',18-trione,12'-hydroxy-5'-(2-methylbutyl)-2'-(1-methylethyl)-, [5'a(R)]- (9CI)
Ergotaman-3',6',18-trione,12'-hydroxy-2'- methyl-5'-(1-methylethyl)-,(2'â,5'R)-